Giorgio Ferrari

This inventor holds 30 USPTO granted patents and 4 published patent applications, plus 2 CIPO patents and 13 EPO patents, primarily in Pharmaceutical Compositions. Top assignees: Simes Societa Italiana Medicinali E Sintetici, Simes, Mapei Spa. Active years: 1976-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Giorgio Ferrari. Retrieved from https://idiyas.com/inventor/giorgio-ferrari

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 30 (Patent Applications = 4)

% Patents Active = 93.3

CIPO Patents = 2 (Patent Applications = 3)

EPO Patents = 13 (Patent Applications = 17)

Average Co-Inventor Count = 2.4

ph-index = 7

Forward Citations = 156(Granted Patents)

Location History:

Milan, I (1976)
Somma Lombardo, IT (2017 - 2019)
Milan, IT (1976 - 2022)

Company Filing History:

8 out of 16

Simes Societa Italiana Medicinali E Sintetici

Charité – Universitätsmedizin Berlin

Simes Societa Italian Medicinali E Sintetici S.p.a.

patent

8. 1 out of 1

Simes Societa Italiana Medicinali E Sintatici S.p.a.

patent

9. 1 out of 1

Simes, Societa Italiana Medicinalle Sintetici

patent

Years Active: 1976-2022

Loading Chart...

Areas of Expertise:

Pharmaceutical Compositions

Antihypertensive Derivatives

Therapeutic Carbamates

Cardiac Treatments

Polyhydroxylated Steroids

Creatinol-O-Phosphates

Ethylenediamine Derivatives

Optical Radiation Detection

Concrete Aggregates

Hydraulic Compositions

Cementitious Compositions

Analog-Digital Converter

30 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11534760 - Device and method for the quantification of cellular and non-cellular blood components (2022-12-27),

2. 11365151 - Accelerating admixture for hydraulic compositions (2022-06-21),

3. 10875032 - Method for producing aggregates from returned concrete (2020-12-29),

4. 10511317 - Electric quantity measuring device comprising an analog-digital converter (2019-12-17),

5. 9722124 - Optical radiation detection system comprising an electric parameter measuring circuit (2017-08-01),

6. 9617185 - Accelerating admixture for cementitious compositions (2017-04-11),

7. 9216925 - Method for producing aggregates from cement compositions (2015-12-22),

8. 5362324 - Zero slump - loss superplasticizer (1994-11-08),

9. 4683245 - Laevorotatory antipode of moprolol as an antihypertensive (1987-07-28),

10. 4528296 - Derivatives of aminopyridinecarboxylic acids and pharmaceutical (1985-07-09),

11. 4507307 - N.sub.1 -Acyl-3-amino-1,2,3,4-tetrahydroquinoline compounds active on (1985-03-26),

12. 4467094 - Precursors to ethylenediamine derivatives (1984-08-21),

13. 4381305 - Ethylenediamine derivatives and pharmaceutical compositions containing (1983-04-26),

14. 4376117 - Creatinol-O-phosphates having therapeutical action (1983-03-08),

15. 4362721 - Penicillanic and cephalosporanic derivatives, preparation thereof, and (1982-12-07),

Title: Giorgio Ferrari: Pioneering Inventor from Milan

Introduction: Giorgio Ferrari is a renowned inventor hailing from Milan, Italy, known for his groundbreaking contributions to various fields of technology and innovation.

Latest Patents: Giorgio Ferrari holds several patents in the areas of renewable energy, sustainable materials, and advanced robotics, showcasing his commitment to creating a more sustainable future.

Career Highlights: With a career spanning over two decades, Giorgio Ferrari has worked with leading research institutions and universities to develop cutting-edge technologies that have revolutionized industries worldwide.

Collaborations: Throughout his career, Giorgio Ferrari has collaborated with top companies, innovative startups, and brilliant minds in the field of engineering, fostering a culture of creativity and excellence.

Conclusion: Giorgio Ferrari's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors and shape the future of technology.

Profile summary based on public USPTO records.